Author

Linnea M. Saunders

Boston University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1 Assay:protein sequence· 1

Frequent Co-Authors

David A. HarrisiD· 1 shared Glenn C. TellingiD· 1 shared Hasier ErañaiD· 1 shared Isabel C. OrbeiD· 1 shared Janelle S. Vultaggio· 1 shared Jason C. BartziD· 1 shared Jean R.P. GatdulaiD· 1 shared Joaquı́n CastillaiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

David A. HarrisORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Leveraging the dominant-negative effect of the kuru-protective G127Vprion protein variant as a novel therapeutic strategy

Jean R.P. Gatdula, Nadia A. Mirza-Romero, Isabel C. Orbe, Linnea M. Saunders, Samantha G Tolton, Janelle S. Vultaggio, Robert C.C. Mercer, Jason C. Bartz, Glenn C. Telling, Hasier Eraña, Joaquı́n Castilla, David A. Harris

This paper demonstrates that the G127V prion protein variant can prevent and suppress prion infection through a dominant-negative effect, suggesting its potential as a therapeutic strategy.

Neurobiology of Disease · Jun 29, 2026Peer-reviewedCell Biology